 | • レポートコード：MRC2-11QY04630 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は皮膚がん診断・治療のグローバル市場について調査・分析したレポートです。種類別（化学線ケラトーゼ（AK）、ベース細胞癌（BCC）、扁平上皮癌（SCC）、メラノーマ）市場規模、用途別（病院、がん研究センター、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別皮膚がん診断・治療の競争状況、市場シェア ・世界の皮膚がん診断・治療市場：種類別市場規模 2015年-2020年（化学線ケラトーゼ（AK）、ベース細胞癌（BCC）、扁平上皮癌（SCC）、メラノーマ） ・世界の皮膚がん診断・治療市場：種類別市場規模予測 2021年-2026年（化学線ケラトーゼ（AK）、ベース細胞癌（BCC）、扁平上皮癌（SCC）、メラノーマ） ・世界の皮膚がん診断・治療市場：用途別市場規模 2015年-2020年（病院、がん研究センター、クリニック） ・世界の皮膚がん診断・治療市場：用途別市場規模予測 2021年-2026年（病院、がん研究センター、クリニック） ・北米の皮膚がん診断・治療市場分析：米国、カナダ ・ヨーロッパの皮膚がん診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの皮膚がん診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の皮膚がん診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの皮膚がん診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Agilent、Amgen、Aqua Pharmaceuticals、AstraZeneca、Bristol-Myers Squibb、Daiichi Sankyo、Elekta、Eli Lilly、Roche、GSK、iCAD、Bausch Health、Merck、Novartis、Pfizer、QIAGEN、Sanofi、Teva Pharmaceutical、Varian Medical Systems ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Skin cancer is the uncontrolled development of anomalous skin cells.
The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer.
Market Analysis and Insights: Global Skin Cancer Diagnosis and Therapeutics Market
The global Skin Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Skin Cancer Diagnosis and Therapeutics Scope and Market Size
Skin Cancer Diagnosis and Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Skin Cancer Diagnosis and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Agilent
Amgen
Aqua Pharmaceuticals
AstraZeneca
Bristol-Myers Squibb
Daiichi Sankyo
Elekta
Eli Lilly
Roche
GSK
iCAD
Bausch Health
Merck
Novartis
Pfizer
QIAGEN
Sanofi
Teva Pharmaceutical
Varian Medical Systems
Market segment by Type, the product can be split into
Actinic Keratoses (AK)
Based cell carcinoma (BCC)
Squamous cell carcinoma (SCC)
Melanoma
Market segment by Application, split into
Hospitals
Cancer research centers
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Skin Cancer Diagnosis and Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Skin Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Actinic Keratoses (AK)
1.4.3 Based cell carcinoma (BCC)
1.4.4 Squamous cell carcinoma (SCC)
1.4.5 Melanoma
1.5 Market by Application
1.5.1 Global Skin Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Cancer research centers
1.5.4 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Skin Cancer Diagnosis and Therapeutics Market Perspective (2015-2026)
2.2 Global Skin Cancer Diagnosis and Therapeutics Growth Trends by Regions
2.2.1 Skin Cancer Diagnosis and Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Skin Cancer Diagnosis and Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Skin Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Skin Cancer Diagnosis and Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Skin Cancer Diagnosis and Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Skin Cancer Diagnosis and Therapeutics Players by Market Size
3.1.1 Global Top Skin Cancer Diagnosis and Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Skin Cancer Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Skin Cancer Diagnosis and Therapeutics Market Concentration Ratio
3.2.1 Global Skin Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Skin Cancer Diagnosis and Therapeutics Revenue in 2019
3.3 Skin Cancer Diagnosis and Therapeutics Key Players Head office and Area Served
3.4 Key Players Skin Cancer Diagnosis and Therapeutics Product Solution and Service
3.5 Date of Enter into Skin Cancer Diagnosis and Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Skin Cancer Diagnosis and Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Skin Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
5.2 Global Skin Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Skin Cancer Diagnosis and Therapeutics Market Size (2015-2020)
6.2 Skin Cancer Diagnosis and Therapeutics Key Players in North America (2019-2020)
6.3 North America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
6.4 North America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Skin Cancer Diagnosis and Therapeutics Market Size (2015-2020)
7.2 Skin Cancer Diagnosis and Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
7.4 Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Skin Cancer Diagnosis and Therapeutics Market Size (2015-2020)
8.2 Skin Cancer Diagnosis and Therapeutics Key Players in China (2019-2020)
8.3 China Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
8.4 China Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Skin Cancer Diagnosis and Therapeutics Market Size (2015-2020)
9.2 Skin Cancer Diagnosis and Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
9.4 Japan Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size (2015-2020)
10.2 Skin Cancer Diagnosis and Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Skin Cancer Diagnosis and Therapeutics Market Size (2015-2020)
11.2 Skin Cancer Diagnosis and Therapeutics Key Players in India (2019-2020)
11.3 India Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
11.4 India Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Skin Cancer Diagnosis and Therapeutics Market Size (2015-2020)
12.2 Skin Cancer Diagnosis and Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Agilent
13.1.1 Agilent Company Details
13.1.2 Agilent Business Overview
13.1.3 Agilent Skin Cancer Diagnosis and Therapeutics Introduction
13.1.4 Agilent Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020))
13.1.5 Agilent Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Skin Cancer Diagnosis and Therapeutics Introduction
13.2.4 Amgen Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Aqua Pharmaceuticals
13.3.1 Aqua Pharmaceuticals Company Details
13.3.2 Aqua Pharmaceuticals Business Overview
13.3.3 Aqua Pharmaceuticals Skin Cancer Diagnosis and Therapeutics Introduction
13.3.4 Aqua Pharmaceuticals Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
13.3.5 Aqua Pharmaceuticals Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Skin Cancer Diagnosis and Therapeutics Introduction
13.4.4 AstraZeneca Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Details
13.5.2 Bristol-Myers Squibb Business Overview
13.5.3 Bristol-Myers Squibb Skin Cancer Diagnosis and Therapeutics Introduction
13.5.4 Bristol-Myers Squibb Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
13.5.5 Bristol-Myers Squibb Recent Development
13.6 Daiichi Sankyo
13.6.1 Daiichi Sankyo Company Details
13.6.2 Daiichi Sankyo Business Overview
13.6.3 Daiichi Sankyo Skin Cancer Diagnosis and Therapeutics Introduction
13.6.4 Daiichi Sankyo Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
13.6.5 Daiichi Sankyo Recent Development
13.7 Elekta
13.7.1 Elekta Company Details
13.7.2 Elekta Business Overview
13.7.3 Elekta Skin Cancer Diagnosis and Therapeutics Introduction
13.7.4 Elekta Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
13.7.5 Elekta Recent Development
13.8 Eli Lilly
13.8.1 Eli Lilly Company Details
13.8.2 Eli Lilly Business Overview
13.8.3 Eli Lilly Skin Cancer Diagnosis and Therapeutics Introduction
13.8.4 Eli Lilly Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
13.8.5 Eli Lilly Recent Development
13.9 Roche
13.9.1 Roche Company Details
13.9.2 Roche Business Overview
13.9.3 Roche Skin Cancer Diagnosis and Therapeutics Introduction
13.9.4 Roche Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
13.9.5 Roche Recent Development
13.10 GSK
13.10.1 GSK Company Details
13.10.2 GSK Business Overview
13.10.3 GSK Skin Cancer Diagnosis and Therapeutics Introduction
13.10.4 GSK Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
13.10.5 GSK Recent Development
13.11 iCAD
10.11.1 iCAD Company Details
10.11.2 iCAD Business Overview
10.11.3 iCAD Skin Cancer Diagnosis and Therapeutics Introduction
10.11.4 iCAD Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
10.11.5 iCAD Recent Development
13.12 Bausch Health
10.12.1 Bausch Health Company Details
10.12.2 Bausch Health Business Overview
10.12.3 Bausch Health Skin Cancer Diagnosis and Therapeutics Introduction
10.12.4 Bausch Health Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
10.12.5 Bausch Health Recent Development
13.13 Merck
10.13.1 Merck Company Details
10.13.2 Merck Business Overview
10.13.3 Merck Skin Cancer Diagnosis and Therapeutics Introduction
10.13.4 Merck Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
10.13.5 Merck Recent Development
13.14 Novartis
10.14.1 Novartis Company Details
10.14.2 Novartis Business Overview
10.14.3 Novartis Skin Cancer Diagnosis and Therapeutics Introduction
10.14.4 Novartis Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
10.14.5 Novartis Recent Development
13.15 Pfizer
10.15.1 Pfizer Company Details
10.15.2 Pfizer Business Overview
10.15.3 Pfizer Skin Cancer Diagnosis and Therapeutics Introduction
10.15.4 Pfizer Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
10.15.5 Pfizer Recent Development
13.16 QIAGEN
10.16.1 QIAGEN Company Details
10.16.2 QIAGEN Business Overview
10.16.3 QIAGEN Skin Cancer Diagnosis and Therapeutics Introduction
10.16.4 QIAGEN Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
10.16.5 QIAGEN Recent Development
13.17 Sanofi
10.17.1 Sanofi Company Details
10.17.2 Sanofi Business Overview
10.17.3 Sanofi Skin Cancer Diagnosis and Therapeutics Introduction
10.17.4 Sanofi Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
10.17.5 Sanofi Recent Development
13.18 Teva Pharmaceutical
10.18.1 Teva Pharmaceutical Company Details
10.18.2 Teva Pharmaceutical Business Overview
10.18.3 Teva Pharmaceutical Skin Cancer Diagnosis and Therapeutics Introduction
10.18.4 Teva Pharmaceutical Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
10.18.5 Teva Pharmaceutical Recent Development
13.19 Varian Medical Systems
10.19.1 Varian Medical Systems Company Details
10.19.2 Varian Medical Systems Business Overview
10.19.3 Varian Medical Systems Skin Cancer Diagnosis and Therapeutics Introduction
10.19.4 Varian Medical Systems Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020)
10.19.5 Varian Medical Systems Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Skin Cancer Diagnosis and Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Skin Cancer Diagnosis and Therapeutics Revenue
Table 3. Ranking of Global Top Skin Cancer Diagnosis and Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Skin Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Actinic Keratoses (AK)
Table 6. Key Players of Based cell carcinoma (BCC)
Table 7. Key Players of Squamous cell carcinoma (SCC)
Table 8. Key Players of Melanoma
Table 9. Global Skin Cancer Diagnosis and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Skin Cancer Diagnosis and Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Skin Cancer Diagnosis and Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Skin Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Skin Cancer Diagnosis and Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Skin Cancer Diagnosis and Therapeutics Players
Table 20. Global Skin Cancer Diagnosis and Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Skin Cancer Diagnosis and Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Skin Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer Diagnosis and Therapeutics as of 2019)
Table 23. Global Skin Cancer Diagnosis and Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Skin Cancer Diagnosis and Therapeutics Product Solution and Service
Table 26. Date of Enter into Skin Cancer Diagnosis and Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Skin Cancer Diagnosis and Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Skin Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Skin Cancer Diagnosis and Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Skin Cancer Diagnosis and Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 36. North America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Skin Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 38. North America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Skin Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 42. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Skin Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Skin Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 48. China Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Skin Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 50. China Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Skin Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 54. Japan Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Skin Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Skin Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 66. India Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Skin Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 68. India Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Skin Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Skin Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Skin Cancer Diagnosis and Therapeutics Market Share (2019-2020)
Table 72. Central & South America Skin Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Skin Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Skin Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Skin Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020)
Table 76. Agilent Company Details
Table 77. Agilent Business Overview
Table 78. Agilent Product
Table 79. Agilent Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 80. Agilent Recent Development
Table 81. Amgen Company Details
Table 82. Amgen Business Overview
Table 83. Amgen Product
Table 84. Amgen Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 85. Amgen Recent Development
Table 86. Aqua Pharmaceuticals Company Details
Table 87. Aqua Pharmaceuticals Business Overview
Table 88. Aqua Pharmaceuticals Product
Table 89. Aqua Pharmaceuticals Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 90. Aqua Pharmaceuticals Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Product
Table 94. AstraZeneca Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 95. AstraZeneca Recent Development
Table 96. Bristol-Myers Squibb Company Details
Table 97. Bristol-Myers Squibb Business Overview
Table 98. Bristol-Myers Squibb Product
Table 99. Bristol-Myers Squibb Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 100. Bristol-Myers Squibb Recent Development
Table 101. Daiichi Sankyo Company Details
Table 102. Daiichi Sankyo Business Overview
Table 103. Daiichi Sankyo Product
Table 104. Daiichi Sankyo Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 105. Daiichi Sankyo Recent Development
Table 106. Elekta Company Details
Table 107. Elekta Business Overview
Table 108. Elekta Product
Table 109. Elekta Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 110. Elekta Recent Development
Table 111. Eli Lilly Business Overview
Table 112. Eli Lilly Product
Table 113. Eli Lilly Company Details
Table 114. Eli Lilly Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 115. Eli Lilly Recent Development
Table 116. Roche Company Details
Table 117. Roche Business Overview
Table 118. Roche Product
Table 119. Roche Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 120. Roche Recent Development
Table 121. GSK Company Details
Table 122. GSK Business Overview
Table 123. GSK Product
Table 124. GSK Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 125. GSK Recent Development
Table 126. iCAD Company Details
Table 127. iCAD Business Overview
Table 128. iCAD Product
Table 129. iCAD Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 130. iCAD Recent Development
Table 131. Bausch Health Company Details
Table 132. Bausch Health Business Overview
Table 133. Bausch Health Product
Table 134. Bausch Health Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 135. Bausch Health Recent Development
Table 136. Merck Company Details
Table 137. Merck Business Overview
Table 138. Merck Product
Table 139. Merck Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 140. Merck Recent Development
Table 141. Novartis Company Details
Table 142. Novartis Business Overview
Table 143. Novartis Product
Table 144. Novartis Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 145. Novartis Recent Development
Table 146. Pfizer Company Details
Table 147. Pfizer Business Overview
Table 148. Pfizer Product
Table 149. Pfizer Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 150. Pfizer Recent Development
Table 151. QIAGEN Company Details
Table 152. QIAGEN Business Overview
Table 153. QIAGEN Product
Table 154. QIAGEN Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 155. QIAGEN Recent Development
Table 156. Sanofi Company Details
Table 157. Sanofi Business Overview
Table 158. Sanofi Product
Table 159. Sanofi Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 160. Sanofi Recent Development
Table 161. Teva Pharmaceutical Company Details
Table 162. Teva Pharmaceutical Business Overview
Table 163. Teva Pharmaceutical Product
Table 164. Teva Pharmaceutical Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 165. Teva Pharmaceutical Recent Development
Table 166. Varian Medical Systems Company Details
Table 167. Varian Medical Systems Business Overview
Table 168. Varian Medical Systems Product
Table 169. Varian Medical Systems Revenue in Skin Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$)
Table 170. Varian Medical Systems Recent Development
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Skin Cancer Diagnosis and Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Actinic Keratoses (AK) Features
Figure 3. Based cell carcinoma (BCC) Features
Figure 4. Squamous cell carcinoma (SCC) Features
Figure 5. Melanoma Features
Figure 6. Global Skin Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Cancer research centers Case Studies
Figure 9. Clinics Case Studies
Figure 10. Skin Cancer Diagnosis and Therapeutics Report Years Considered
Figure 11. Global Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Skin Cancer Diagnosis and Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Skin Cancer Diagnosis and Therapeutics Market Share by Players in 2019
Figure 16. Global Top Skin Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer Diagnosis and Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Skin Cancer Diagnosis and Therapeutics Revenue in 2019
Figure 18. North America Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Skin Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
肺がん診断・治療の世界市場（～2026年） Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the …- 大腸がん診断・治療の世界市場（～2026年） Colorectal cancer is the development of cancer from the colonor rectum. The main market drivers are increasing cancer prevention initiatives, technological advancements in radiology and chemotherapy, and increasing incidence and prevalence of colorectal cancer. Market Analysis and Insights: Global C…
- 骨肉腫診断・治療の世界市場（～2026年） Bone cancer is a malignant tumor that arises from the cells that make up the bones of the body. Robust healthcare expenditure in developed countries, genetic disorder, and development of stem cell transplant technology are some of the major factors that drive the growth of the market. Rising geriatr…
- 中咽頭がん診断・治療の世界市場（～2026年） Oropharyngeal cancer is a malignant tumour that starts in the cells of the oropharynx. Rising prevalence of oropharyngeal cancer has been the major factor driving the market growth. Additionally, increasing geriatric population and rising oropharyngeal cancer associated with them is another factor d…
- 基底細胞がん（BCC）治療薬の世界市場（～2026年） Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening…